FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
17/6/761
02-0586fjev1    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Linden, T.
Right arrow Articles by Wenger, R. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Linden, T.
Right arrow Articles by Wenger, R. H.
The FASEB Journal Express Article doi:10.1096/fj.02-0586fje
Published online February 19, 2003

The antimycotic ciclopirox olamine induces HIF-1α stability, VEGF expression, and angiogenesis

Tobias Linden, Dörthe M. Katschinski, Katrin Eckhardt, Annette Scheid, Horst Pagel, and Roland H. Wenger

E-mail contact: wenr{at}medizin.uni-leipzig.de

The heterodimeric hypoxia-inducible factor (HIF)-1 is a master regulator of oxygen homeostasis. Protein stability and transactivation function of the α subunit are controlled by iron- and oxygen-dependent hydroxylation of proline and asparagine residues. The anti-mycotic ciclopirox olamine (CPX) is a lipophilic bidentate iron chelator that stabilizes HIF-1α under normoxic conditions at lower concentrations than other iron chelators, probably by inhibiting HIF-1α hydroxylation. As shown by the inhibition of iron-dependent quenching of FITC-labeled deferoxamine (DFX) fluorescence, CPX appears to have an even higher affinity for iron than DFX. Initial observations that treatment with 1% CPX, but not with placebo, occasionally caused reddening of wound margins in a mouse skin wound model prompted us to investigate the capability of CPX to induce angiogenesis. CPX-induced HIF-1-mediated reporter gene activity and endogenous HIF-1 target gene expression, including elevation of transcription, mRNA, and protein levels of the vascular endothelial growth factor (VEGF). In the chick chorioallantoic membrane assay, inert polymer disks containing CPX but not the solvent alone induced angiogenesis. In summary, these results suggest that CPX induces angiogenesis in vivo via HIF-1 and VEGF induction. Therefore, CPX might serve as an alternative to recombinant VEGF treatment or to VEGF gene therapy for therapeutic angiogenesis.

Key words: erythropoietin · hypoxia · iron · oxygen sensor · vascular endothelial growth factor




This article has been cited by other articles:


Home page
 Mol. Pharmacol.Home page
H. Cho, H.-Y. Lee, D.-R. Ahn, S. Y. Kim, S. Kim, K. B. Lee, Y. M. Lee, H. Park, and E. G. Yang
Baicalein Induces Functional Hypoxia-Inducible Factor-1{alpha} and Angiogenesis
Mol. Pharmacol., July 1, 2008; 74(1): 70 - 81.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
T. G. Nacak, A. Alajati, K. Leptien, C. Fulda, H. Weber, T. Miki, F. S. Czepluch, J. Waltenberger, T. Wieland, H. G. Augustin, et al.
The BTB-Kelch Protein KLEIP Controls Endothelial Migration and Sprouting Angiogenesis
Circ. Res., April 27, 2007; 100(8): 1155 - 1163.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Fahling, R. Mrowka, A. Steege, P. Martinka, P. B. Persson, and B. J. Thiele
Heterogeneous Nuclear Ribonucleoprotein-A2/B1 Modulate Collagen Prolyl 4-Hydroxylase, {alpha} (I) mRNA Stability
J. Biol. Chem., April 7, 2006; 281(14): 9279 - 9286.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
N. O. Ibrahim, T. Hahn, C. Franke, D. P. Stiehl, R. Wirthner, R. H. Wenger, and D. M. Katschinski
Induction of the Hypoxia-Inducible Factor System by Low Levels of Heat Shock Protein 90 Inhibitors
Cancer Res., December 1, 2005; 65(23): 11094 - 11100.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
F. Martin, T. Linden, D. M. Katschinski, F. Oehme, I. Flamme, C. K. Mukhopadhyay, K. Eckhardt, J. Troger, S. Barth, G. Camenisch, et al.
Copper-dependent activation of hypoxia-inducible factor (HIF)-1: implications for ceruloplasmin regulation
Blood, June 15, 2005; 105(12): 4613 - 4619.
[Abstract] [Full Text] [PDF]

Home page
 VASC ENDOVASCULAR SURGHome page
I. Sheikh, G. Tchekanov, D. Krum, J. Hare, M. Djelmami-Hani, R. Maddikunta, M. E. Mortada, P. Karakozov, I. Baibekov, J. Hauck, et al.
Effect of Electrical Stimulation on Arteriogenesis and Angiogenesis after Bilateral Femoral Artery Excision in the Rabbit Hind-Limb Ischemia Model
Vascular and Endovascular Surgery, May 1, 2005; 39(3): 257 - 265.
[Abstract] [PDF]

Home page
 J. Cell Sci.Home page
D. Szuts and T. Krude
Cell cycle arrest at the initiation step of human chromosomal DNA replication causes DNA damage
J. Cell Sci., October 1, 2004; 117(21): 4897 - 4908.
[Abstract] [Full Text] [PDF]

Home page
 PhysiologyHome page
G. L. Semenza
Hydroxylation of HIF-1: Oxygen Sensing at the Molecular Level
Physiology, August 1, 2004; 19(4): 176 - 182.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
R. Depping, S. Hagele, K. F. Wagner, R. J. Wiesner, G. Camenisch, R. H. Wenger, and D. M. Katschinski
A Dominant-Negative Isoform of Hypoxia-Inducible Factor-1{alpha} Specifically Expressed in Human Testis
Biol Reprod, July 1, 2004; 71(1): 331 - 339.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2003 by The Federation of American Societies for Experimental Biology.